Company Filing History:
Years Active: 1998
Title: Ravindar N Girotra: Innovator in Beta3 Adrenergic Receptor Agonists
Introduction
Ravindar N Girotra is a notable inventor based in the United States. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as beta3 adrenergic receptor agonists. His work is particularly relevant in the treatment of conditions such as diabetes, obesity, and gastrointestinal diseases.
Latest Patents
Ravindar N Girotra holds a patent for "Catecholamine Surrogates Useful As .beta.3 Agonists." This patent describes compounds of a specific formula that can be utilized in pharmaceutical applications. The compounds are designed to interact with beta3 adrenergic receptors, which play a crucial role in metabolic processes.
Career Highlights
Girotra is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there focuses on innovative drug development aimed at improving patient outcomes in various therapeutic areas. Despite having no patents listed under his name, his research contributions are invaluable to the field.
Collaborations
Ravindar N Girotra has collaborated with notable colleagues such as William N Washburn and Philip Michael Sher. These collaborations have likely enhanced the scope and impact of his research efforts.
Conclusion
Ravindar N Girotra is a dedicated inventor whose work in beta3 adrenergic receptor agonists has the potential to significantly impact the treatment of metabolic diseases. His contributions to pharmacology continue to be recognized within the scientific community.